Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06853964 · ClinicalTrials.gov registry record
Retrospective Study of AlloMend Acellular Dermal Matrix (ADM) Allograft and Pre-Pectoral Breast Reconstruction
A clinical trial of Pre-Pectoral Breast Reconstruction Following Mastectomy, sponsored by AlloSource.
- Active
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06853964 is a study of Pre-Pectoral Breast Reconstruction Following Mastectomy that is active but no longer recruiting, run by AlloSource. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06853964, a study of Pre-Pectoral Breast Reconstruction Following Mastectomy, is active but no longer recruiting, sponsored by AlloSource.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This retrospective, single-site study will provide information regarding the efficiency of AlloMend® Acellular Dermal Matrix allograft in Pre-Pectoral Breast Reconstruction surgery following a single or double mastectomy.
Conditions Studied
Interventions
- OTHER AlloMend® Acellular Dermal Matrix allograft
Study Locations (1)
Nevada
- Janiga MDs Plastic Surgery and Cosmetic Center - Reno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-01-27 |
| Est. Completion | 2026-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06853964
The ClinicalTrials.gov registry entry for NCT06853964 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AlloSource, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pre-Pectoral Breast Reconstruction Following Mastectomy appearing as the primary indexed condition, and to 1 intervention - of which AlloMend® Acellular Dermal Matrix allograft is the first listed.
NCT06853964 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.
Frequently Asked Questions
What is clinical trial NCT06853964 about?
NCT06853964 is a clinical study titled "Retrospective Study of AlloMend Acellular Dermal Matrix (ADM) Allograft and Pre-Pectoral Breast Reconstruction". This retrospective, single-site study will provide information regarding the efficiency of AlloMend® Acellular Dermal Matrix allograft in Pre-Pectoral Breast Reconstruction surgery following a single or double mastectomy.
What is the current status of trial NCT06853964?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2025-01-27. Estimated completion is 2026-05-31.
What conditions does trial NCT06853964 study?
This clinical trial studies the following conditions: Pre-Pectoral Breast Reconstruction Following Mastectomy.
What interventions are being tested in trial NCT06853964?
The interventions under investigation include: AlloMend® Acellular Dermal Matrix allograft (OTHER).
Who is sponsoring clinical trial NCT06853964?
This trial is sponsored by AlloSource, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06853964 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.